|
|
|
|
EAE-PLP |
|
| |
|
| Model: |
PLP139-151 induced relapsing-remitting EAE in SJL/J mice |
|
| Animal: |
SJL/J |
|
| Immunogen: |
PLP139-151 peptide |
|
| Study duration: |
40-50 days (in life) |
|
| Pathological features: |
- |
Relapse_remitting model |
|
- |
Inflammatory Infiltration and de-myelination in CNS |
|
| Suitability: |
- |
De-myelination,neuron regeneration and T cell response |
|
- |
Not suited for study of B cell involvement/intervention |
- |
Efficacy study against relapse |
|
| Parameter measures: |
- |
Body weight |
|
- |
clinical score |
- |
Histo-pathological assessment |
- |
Cytokine ELISA (optional) |
- |
RT-qPCR (optional) |
- |
IHC (optional) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
The Latest Generation of Auto Patch Clamp Platform Launched at HDB  |
|
---------------------- |
WuXi Biology/HD Biosciences Presented at Webinar of "New Technologies for Target Discovery and Validation" |
|
---------------------- |
HD Biosciences Merges with WuXi AppTec |
|
|
|
|
|
|
|
|
|
|
 |
|
|
HD Biosciences (China) Co.,Ltd
590 Ruiqing Road
Zhangjiang East Campus, Pudong,
Shanghai 201201,
P.R.China
Tel: +86 (21) 5116 3700
Fax: +86 (21) 5116 3766
|
|
|
|
|
沪公网安备 31011502003320号